The MarketWatch News Department was not involved in the creation of this content. New Research Confirms Hb Variant Test for Sickle Cell, Gazelle(TM), Useful for Screening and Tracking Treatment ...

Scientists have found a potential new gene variant target to treat sickle cell disease, an inherited blood disorder that affects about 300,000 people globally each year, with limited treatment options ...

Despite a Trump administration push, there are few facilities offering the complex treatment in the rural areas where many ...

Gene and cell therapies bring fresh hope to people with genetic disorders, but recovery can be complex and long-term support remains sparse. For most of her life, Genesis Jones’s daily routine ...

Sickle cell disease (SCD) is a group of genetic blood disorders. A person inherits SCD from their parents when they inherit two copies of the sickle cell gene, one from each parent. This hereditary ...

Sickle cell anemia is the most severe form of sickle cell disease (SCD). Treatments for sickle cell anemia include medications, blood transfusions, and bone marrow transplants. SCD is a group of ...

Contrary to misconceptions among medical professionals and patients alike, individuals born with sickle cell trait (SCT) show no risk of experiencing the acute pain crises known to occur with sickle ...

This article is part of The Athletic’s series marking UK Black History Month. To view the whole collection, click here. Lassana Diarra was preparing for the 2010 World Cup in South Africa. The ...

Sickle cell disease is one of the most common inherited blood disorders worldwide, with a particularly heavy burden in sub-Saharan Africa. Every year, hundreds of thousands of infants are born with ...